AGX-73

N/A

Report date: 2022/03/10 17:51:07

Base Information

Drug NameAGX-73

Drug Alias NameAGX-73

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAXL receptor tyrosine kinase inhibitorsDiscoidin domain-containing receptor 2 inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors

TargetsAXL receptor tyrosine kinaseDiscoidin domain-containing receptor 2Tyrosine-protein kinase receptor FLT3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAngex Pharmaceutical HongKong Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAngex Pharmaceutical HongKong Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A